NanoVibronix Announces Selection of Leading International Contract Manufacturer to Support Rapid Scale-up, Lower Price Points and Enhance Profitability
11 déc. 2018 09h01 HE
|
NanoVibronix, Inc.
ELMSFORD, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections
06 déc. 2018 08h00 HE
|
NanoVibronix, Inc.
UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less in 25 of 29 patients in the treatment group No reported infections in the treatment group versus 27%...
NanoVibronix Provides Business Update for the Third Quarter of 2018
14 nov. 2018 08h00 HE
|
NanoVibronix, Inc.
Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's...
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
22 oct. 2018 16h47 HE
|
NanoVibronix, Inc.
ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix Provides Business Update for the Second Quarter of 2018
16 août 2018 08h00 HE
|
NanoVibronix, Inc.
Revenue increases 153% for the second quarter of 2018 ELMSFORD, N.Y., Aug. 16, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company's...
NanoVibronix Reports Successful Trial Results for Use of PainShield™ in Patients with Trigeminal Neuralgia; Reinforces Potential as Alternative to Opioids and Surgical Interventions
24 juil. 2018 07h30 HE
|
NanoVibronix, Inc.
ELMSFORD, N.Y., July 24, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave...
NanoVibronix Announces Exclusive Agreement for Distribution of PainShield® and WoundShield® in Israel
05 juin 2018 07h00 HE
|
NanoVibronix, Inc.
ELMSFORD, N.Y., June 05, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix Provides Business Update for the First Quarter 2018
17 mai 2018 09h44 HE
|
NanoVibronix, Inc.
ELMSFORD, N.Y., May 17, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW)...
NanoVibronix Partners with Fabrication Enterprises, Inc. for Distribution of PainShield® in the United States
09 mai 2018 07h00 HE
|
NanoVibronix, Inc.
ELMSFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave...
NanoVibronix to Present at the 3rd Annual Disruptive Growth & Healthcare Conference Hosted by RHK Capital and Reed Smith
01 mai 2018 08h39 HE
|
NanoVibronix, Inc.
NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW)...